IMMUNIC, INC. — Director's Dealing 2016

Aug 17, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: VITAL THERAPIES INC (VTL)
CIK: 0001280776
Period of Report: 2016-08-15

Reporting Person: Henry Andrew (VP, Clinical Operations)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-08-15	Stock Option (right to buy)	$6.35	A	3152	Acquired	2026-08-14	Common Stock (3152.0)	Indirect

Footnotes

F1: One forty-eighth (1/48th) of the shares of common stock subject to the option shall vest monthly beginning on July 1, 2016, such that all of the shares of common stock subject to the option are vested by July 1, 2020, subject to the daughter's continuing to be a Service Provider (as defined in the 2014 Equity Incentive Plan (the "Plan")) through each vesting date.

F2: The reporting person disclaims beneficial ownership of the securities indicated, and the reporting herein of such securities shall not be construed as an admission that the reporting person is the beneficial owner thereof for purposes of Section 16 or for any other purpose.